Paradigm Biocapital Advisors »

Pharvaris N V shares owned by Paradigm Biocapital Advisors

Quarter-by-quarter ownership of Pharvaris N V (PHVS) shares owned by Paradigm Biocapital Advisors from 13F filings

Historical chart of Paradigm Biocapital Advisors investment in Pharvaris N V

Tip: Access up to 7 years of quarterly data

All positions including Pharvaris N V held by Paradigm Biocapital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharvaris N V by Paradigm Biocapital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $46M 1.8M 24.95
2025-06-30 $19M 1.1M 17.60

More positions owned by Paradigm Biocapital Advisors

Nuvalent Inc-a (NUVL)
Merus N V Call Option (MRUS)
Arcellx Common Stock (ACLX)
Revolution Medicines (RVMD)
Tarsus Pharmaceuticals (TARS)
Vaxcyte (PCVX)
Abivax Sa Sponsored Ads (ABVX)
Genmab A/s Sponsored Ads (GMAB)
Agios Pharmaceuticals Call Option (AGIO)
Crinetics Pharmaceuticals In (CRNX)
Spdr Series Trust S&p Biotech Put Option (XBI)
Edgewise Therapeutics (EWTX)
Cidara Therapeutics Com New (CDTX)
Urogen Pharma (URGN)
Scholar Rock Hldg Corp (SRRK)

View all positions for Paradigm Biocapital Advisors

Top funds holding Pharvaris N V

General Atlantic
FMR
Foresite Capital Management IV
venBio Partners
Viking Global Investors
EQT Fund Management S.a r.l.
Bain Capital Life Sciences Investors
Deerfield Management Company
Commodore Capital
Paradigm Biocapital Advisors
Novo A/S
Wellington Management Company
Cormorant Asset Management
Saturn V Capital Management
5AM Venture Management

View all funds holding Pharvaris N V